pentobarbital will lower the extent or outcome of fostemsavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.pentobarbital will decrease the extent or impact of eplerenone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unidentified.pentobarbital will lessen the extent or effect of solifen